HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,969,216 | -18.7% | 88,962 | -22.7% | 1.46% | -14.0% |
| Q2 2023 | $9,796,294 | -15.9% | 115,061 | -18.2% | 1.70% | -33.0% |
| Q1 2023 | $11,646,235 | +11.9% | 140,740 | +6.3% | 2.53% | -8.6% |
| Q4 2022 | $10,411,530 | +21.5% | 132,378 | +14.3% | 2.77% | +13.7% |
| Q3 2022 | $8,572,000 | +425.9% | 115,797 | +363.2% | 2.44% | +306.2% |
| Q2 2022 | $1,630,000 | -16.1% | 25,000 | +42.9% | 0.60% | +33.0% |
| Q1 2021 | $1,943,000 | -28.0% | 17,500 | -42.0% | 0.45% | -40.7% |
| Q2 2020 | $2,700,000 | +78.8% | 30,147 | +99.0% | 0.76% | +8.7% |
| Q1 2020 | $1,510,000 | -78.2% | 15,147 | -74.9% | 0.70% | -65.0% |
| Q4 2019 | $6,923,000 | – | 60,250 | – | 2.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |